Scholarlink

<p>Endocrine-disrupting chemicals (EDCs) are increasingly implicated in the development of metabolic disorders such as type 2 diabetes mellitus (T2DM). As hepatic dysfunction is a hallmark of early metabolic disease, we investigated how EDCs may contribute to glucose dysregulation using human HepaRG cells. Ten EDCs—bisphenol A (BPA), bisphenol F (BPF), bisphenol S (BPS), cadmium chloride (CdCl<sub>2</sub>, 1&#xa0;µM), butylparaben (BP), 1,1-dichloro-2,2-bis(4-chlorophenyl)ethene (p,p′-DDE), dibutyl phthalate (DBP), di(2-ethylhexyl) phthalate (DEHP), perfluorooctanoic acid (PFOA), and perfluorooctanesulfonic acid (PFOS)—were tested at 25&#xa0;µM for 5&#xa0;days. We assessed multiple endpoints related to carbohydrate metabolism, including gene expression, mitochondrial function, glycogen content, glucose export, glycolytic capacity, and lactate release. Among the tested compounds, p,p′-DDE induced the most pronounced metabolic disruption, significantly reducing glycogen storage, glycolytic capacity, lactate export, and the expression of key genes involved in glucose metabolism. Using luciferase-based reporter cell lines, p,p′-DDE was found to activate primarily the nuclear receptors constitutive androstane receptor (CAR) and pregnane X receptor (PXR). However, siRNA-mediated knockdown of these receptors did not reverse the changes induced by p,p′-DDE in gene expression, suggesting a more complex or alternative mechanism of action. These findings demonstrate that p,p′-DDE perturbs hepatic carbohydrate metabolism and may contribute to the pathogenesis of T2DM, highlighting the need for further mechanistic investigation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessment of endocrine disruptor impact on carbohydrate metabolism in the HepaRG human hepatic cell line

  • 期刊论文

  • 发表日期：

    2026年1月28日

查看全文
  • Kévin Bernal,
  • Arnaud Tête,
  • Béatrice Le-Grand,
  • Patrick Balaguer,
  • Min Ji Kim,
  • Xavier Coumoul,
  • Etienne B. Blanc

摘要

Endocrine-disrupting chemicals (EDCs) are increasingly implicated in the development of metabolic disorders such as type 2 diabetes mellitus (T2DM). As hepatic dysfunction is a hallmark of early metabolic disease, we investigated how EDCs may contribute to glucose dysregulation using human HepaRG cells. Ten EDCs—bisphenol A (BPA), bisphenol F (BPF), bisphenol S (BPS), cadmium chloride (CdCl2, 1 µM), butylparaben (BP), 1,1-dichloro-2,2-bis(4-chlorophenyl)ethene (p,p′-DDE), dibutyl phthalate (DBP), di(2-ethylhexyl) phthalate (DEHP), perfluorooctanoic acid (PFOA), and perfluorooctanesulfonic acid (PFOS)—were tested at 25 µM for 5 days. We assessed multiple endpoints related to carbohydrate metabolism, including gene expression, mitochondrial function, glycogen content, glucose export, glycolytic capacity, and lactate release. Among the tested compounds, p,p′-DDE induced the most pronounced metabolic disruption, significantly reducing glycogen storage, glycolytic capacity, lactate export, and the expression of key genes involved in glucose metabolism. Using luciferase-based reporter cell lines, p,p′-DDE was found to activate primarily the nuclear receptors constitutive androstane receptor (CAR) and pregnane X receptor (PXR). However, siRNA-mediated knockdown of these receptors did not reverse the changes induced by p,p′-DDE in gene expression, suggesting a more complex or alternative mechanism of action. These findings demonstrate that p,p′-DDE perturbs hepatic carbohydrate metabolism and may contribute to the pathogenesis of T2DM, highlighting the need for further mechanistic investigation.